291 related articles for article (PubMed ID: 16842157)
1. Hsp90: a novel target for cancer therapy.
Solit DB; Rosen N
Curr Top Med Chem; 2006; 6(11):1205-14. PubMed ID: 16842157
[TBL] [Abstract][Full Text] [Related]
2. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.
Stravopodis DJ; Margaritis LH; Voutsinas GE
Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746
[TBL] [Abstract][Full Text] [Related]
3. Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer.
Haque A; Alam Q; Alam MZ; Azhar EI; Sait KH; Anfinan N; Mushtaq G; Kamal MA; Rasool M
Curr Pharm Des; 2016; 22(20):2947-59. PubMed ID: 27013225
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 molecular chaperone inhibitors: are we there yet?
Neckers L; Workman P
Clin Cancer Res; 2012 Jan; 18(1):64-76. PubMed ID: 22215907
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents.
Miyata Y
Curr Pharm Des; 2005; 11(9):1131-8. PubMed ID: 15853661
[TBL] [Abstract][Full Text] [Related]
6. HSP90 inhibitors: current development and potential in cancer therapy.
Sidera K; Patsavoudi E
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):1-20. PubMed ID: 23312026
[TBL] [Abstract][Full Text] [Related]
7. Using natural product inhibitors to validate Hsp90 as a molecular target in cancer.
Neckers L
Curr Top Med Chem; 2006; 6(11):1163-71. PubMed ID: 16842153
[TBL] [Abstract][Full Text] [Related]
8. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
Kim T; Keum G; Pae AN
Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
[TBL] [Abstract][Full Text] [Related]
9. Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update.
Neckers L; Neckers K
Expert Opin Emerg Drugs; 2005 Feb; 10(1):137-49. PubMed ID: 15757409
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in Hsp90 inhibitors as antitumor agents.
Messaoudi S; Peyrat JF; Brion JD; Alami M
Anticancer Agents Med Chem; 2008 Oct; 8(7):761-82. PubMed ID: 18855578
[TBL] [Abstract][Full Text] [Related]
11. HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy.
Hwang M; Moretti L; Lu B
Curr Med Chem; 2009; 16(24):3081-92. PubMed ID: 19689285
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Discovery of Novel HSP90 Inhibitors: An Update from 2014.
Xiao Y; Liu Y
Curr Drug Targets; 2020; 21(3):302-317. PubMed ID: 31465284
[TBL] [Abstract][Full Text] [Related]
13. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
[TBL] [Abstract][Full Text] [Related]
14. Update on Hsp90 inhibitors in clinical trial.
Kim YS; Alarcon SV; Lee S; Lee MJ; Giaccone G; Neckers L; Trepel JB
Curr Top Med Chem; 2009; 9(15):1479-92. PubMed ID: 19860730
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting HSP90 to treat cancer: a strategy in evolution.
Whitesell L; Santagata S; Lin NU
Curr Mol Med; 2012 Nov; 12(9):1108-24. PubMed ID: 22804235
[TBL] [Abstract][Full Text] [Related]
16. Recent updates on the development of ganetespib as a Hsp90 inhibitor.
Choi HK; Lee K
Arch Pharm Res; 2012 Nov; 35(11):1855-9. PubMed ID: 23212626
[TBL] [Abstract][Full Text] [Related]
17. Discovery and development of purine-scaffold Hsp90 inhibitors.
Chiosis G
Curr Top Med Chem; 2006; 6(11):1183-91. PubMed ID: 16842155
[TBL] [Abstract][Full Text] [Related]
18. Targeting multiple signal transduction pathways through inhibition of Hsp90.
Zhang H; Burrows F
J Mol Med (Berl); 2004 Aug; 82(8):488-99. PubMed ID: 15168026
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone.
Workman P
Cancer Detect Prev; 2002; 26(6):405-10. PubMed ID: 12507224
[TBL] [Abstract][Full Text] [Related]
20. Purine-scaffold Hsp90 inhibitors.
Chiosis G; Tao H
IDrugs; 2006 Nov; 9(11):778-82. PubMed ID: 17096299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]